{"id":76653,"date":"2026-08-26T12:39:58","date_gmt":"2026-08-26T04:39:58","guid":{"rendered":"https:\/\/flcube.com\/?p=76653"},"modified":"2026-08-26T12:39:59","modified_gmt":"2026-08-26T04:39:59","slug":"takeda-and-ant-group-form-digital-healthcare-partnership-to-advance-ai-driven-patient-care-in-china","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=76653","title":{"rendered":"Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI\u2011Driven Patient Care in China"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Takeda Pharmaceutical Company Limited China (<a href=\"https:\/\/www.google.com\/finance\/beta\/quote\/4502:TYO\">TYO: 4502<\/a>; <a href=\"https:\/\/www.google.com\/finance\/beta\/quote\/TAK:NYSE\">NYSE: TAK<\/a>)<\/strong> entered into a <strong>partnership agreement<\/strong> with <strong>Ant Group<\/strong>, combining Takeda&#8217;s expertise and medical insights in key disease areas with Ant Group&#8217;s strengths in <strong>artificial intelligence (AI), digital platforms, and ecosystem connectivity<\/strong>. The two parties will collaborate around patient needs and healthcare service scenarios, exploring new models for digital technology\u2011enabled healthcare innovation and driving healthcare services toward <strong>full\u2011lifecycle, data\u2011driven, intelligent, and health\u2011centric development<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-partnership-overview\" class=\"wp-block-heading\">Partnership Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Partners<\/strong><\/td><td>Takeda China (TYO: 4502; NYSE: TAK) and Ant Group<\/td><\/tr><tr><td><strong>Announcement Date<\/strong><\/td><td>25 Aug 2026<\/td><\/tr><tr><td><strong>Core Focus<\/strong><\/td><td>Digital technology\u2011enabled healthcare innovation centred on patient needs<\/td><\/tr><tr><td><strong>Key Capabilities<\/strong><\/td><td>Takeda&#8217;s medical expertise \u00d7 Ant Group&#8217;s AI, digital platforms, and ecosystem connectivity<\/td><\/tr><tr><td><strong>Vision<\/strong><\/td><td>Full\u2011lifecycle, data\u2011driven, intelligent, health\u2011centric healthcare services<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-strategic-focus-areas\" class=\"wp-block-heading\">Strategic Focus Areas<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Patient\u2011Centric Solutions:<\/strong> Disease awareness, patient education, patient services, and long\u2011term management, with digital solutions explored across the <strong>entire patient journey<\/strong><\/li>\n\n\n\n<li><strong>Physician Engagement:<\/strong> Physician education, academic interaction, and disease\u2011specific ecosystem development<\/li>\n\n\n\n<li><strong>Innovative Payment Models:<\/strong> Leveraging internet healthcare ecosystems and payment platform capabilities to improve patient accessibility to treatment<\/li>\n\n\n\n<li><strong>Data &amp; Evidence:<\/strong> Utilisation of real\u2011world research and disease area insights to inform care delivery<\/li>\n\n\n\n<li><strong>R&amp;D Acceleration:<\/strong> Exploration of digital platforms to accelerate drug and new indication development<\/li>\n\n\n\n<li><strong>Public Health:<\/strong> Initiation of public health education programs in specific disease fields<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-impact-amp-outlook\" class=\"wp-block-heading\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Platform + Pharma Convergence:<\/strong> The partnership pairs one of China&#8217;s most connected digital ecosystems with a global pharmaceutical leader, signalling accelerating integration of AI and healthcare delivery in China.<\/li>\n\n\n\n<li><strong>Patient Accessibility:<\/strong> Innovative payment and internet\u2011healthcare models could materially lower barriers to treatment access, a priority as China&#8217;s healthcare system shifts toward value\u2011based, patient\u2011centred care.<\/li>\n\n\n\n<li><strong>Strategic Positioning:<\/strong> For <strong>Takeda<\/strong>, the collaboration strengthens its China commercial and digital footprint across key disease areas; for <strong>Ant Group<\/strong>, it extends healthcare into its AI and platform strategy.<\/li>\n\n\n\n<li><strong>Catalyst Watch:<\/strong> Early focus areas, disease\u2011specific pilots, and payment model trials will be key milestones to monitor as the partnership moves from framework to execution.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding the scope, implementation, and potential impact of the partnership between Takeda and Ant Group. Actual results may differ due to risks including regulatory developments, technology adoption, and execution timelines.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Takeda Pharmaceutical Company Limited China (TYO: 4502; NYSE: TAK) entered into a partnership agreement with&#8230;<\/p>\n","protected":false},"author":1,"featured_media":76655,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10,93,4908],"tags":[99,874,345,1141],"class_list":["post-76653","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","category-digital","category-pic","tag-ai","tag-nyse-tak","tag-takeda","tag-tyo-4502"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI\u2011Driven Patient Care in China - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Takeda Pharmaceutical Company Limited China (TYO: 4502; NYSE: TAK) entered into a partnership agreement with Ant Group, combining Takeda&#039;s expertise and medical insights in key disease areas with Ant Group&#039;s strengths in artificial intelligence (AI), digital platforms, and ecosystem connectivity. The two parties will collaborate around patient needs and healthcare service scenarios, exploring new models for digital technology\u2011enabled healthcare innovation and driving healthcare services toward full\u2011lifecycle, data\u2011driven, intelligent, and health\u2011centric development.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=76653\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI\u2011Driven Patient Care in China\" \/>\n<meta property=\"og:description\" content=\"Takeda Pharmaceutical Company Limited China (TYO: 4502; NYSE: TAK) entered into a partnership agreement with Ant Group, combining Takeda&#039;s expertise and medical insights in key disease areas with Ant Group&#039;s strengths in artificial intelligence (AI), digital platforms, and ecosystem connectivity. The two parties will collaborate around patient needs and healthcare service scenarios, exploring new models for digital technology\u2011enabled healthcare innovation and driving healthcare services toward full\u2011lifecycle, data\u2011driven, intelligent, and health\u2011centric development.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=76653\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-26T04:39:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-26T04:39:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/2603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=76653#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=76653\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI\u2011Driven Patient Care in China\",\"datePublished\":\"2026-08-26T04:39:58+00:00\",\"dateModified\":\"2026-08-26T04:39:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=76653\"},\"wordCount\":400,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=76653#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/2603.webp\",\"keywords\":[\"AI\",\"NYSE: TAK\",\"Takeda\",\"TYO: 4502\"],\"articleSection\":[\"Company\",\"Deals\",\"Digital\",\"PIC\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=76653#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=76653\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=76653\",\"name\":\"Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI\u2011Driven Patient Care in China - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=76653#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=76653#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/2603.webp\",\"datePublished\":\"2026-08-26T04:39:58+00:00\",\"dateModified\":\"2026-08-26T04:39:59+00:00\",\"description\":\"Takeda Pharmaceutical Company Limited China (TYO: 4502; NYSE: TAK) entered into a partnership agreement with Ant Group, combining Takeda's expertise and medical insights in key disease areas with Ant Group's strengths in artificial intelligence (AI), digital platforms, and ecosystem connectivity. The two parties will collaborate around patient needs and healthcare service scenarios, exploring new models for digital technology\u2011enabled healthcare innovation and driving healthcare services toward full\u2011lifecycle, data\u2011driven, intelligent, and health\u2011centric development.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=76653#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=76653\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=76653#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/2603.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/2603.webp\",\"width\":1080,\"height\":608,\"caption\":\"Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI\u2011Driven Patient Care in China\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=76653#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI\u2011Driven Patient Care in China\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI\u2011Driven Patient Care in China - Insight, China&#039;s Pharmaceutical Industry","description":"Takeda Pharmaceutical Company Limited China (TYO: 4502; NYSE: TAK) entered into a partnership agreement with Ant Group, combining Takeda's expertise and medical insights in key disease areas with Ant Group's strengths in artificial intelligence (AI), digital platforms, and ecosystem connectivity. The two parties will collaborate around patient needs and healthcare service scenarios, exploring new models for digital technology\u2011enabled healthcare innovation and driving healthcare services toward full\u2011lifecycle, data\u2011driven, intelligent, and health\u2011centric development.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=76653","og_locale":"en_US","og_type":"article","og_title":"Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI\u2011Driven Patient Care in China","og_description":"Takeda Pharmaceutical Company Limited China (TYO: 4502; NYSE: TAK) entered into a partnership agreement with Ant Group, combining Takeda's expertise and medical insights in key disease areas with Ant Group's strengths in artificial intelligence (AI), digital platforms, and ecosystem connectivity. The two parties will collaborate around patient needs and healthcare service scenarios, exploring new models for digital technology\u2011enabled healthcare innovation and driving healthcare services toward full\u2011lifecycle, data\u2011driven, intelligent, and health\u2011centric development.","og_url":"https:\/\/flcube.com\/?p=76653","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-08-26T04:39:58+00:00","article_modified_time":"2026-08-26T04:39:59+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/2603.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=76653#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=76653"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI\u2011Driven Patient Care in China","datePublished":"2026-08-26T04:39:58+00:00","dateModified":"2026-08-26T04:39:59+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=76653"},"wordCount":400,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=76653#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/2603.webp","keywords":["AI","NYSE: TAK","Takeda","TYO: 4502"],"articleSection":["Company","Deals","Digital","PIC"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=76653#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=76653","url":"https:\/\/flcube.com\/?p=76653","name":"Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI\u2011Driven Patient Care in China - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=76653#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=76653#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/2603.webp","datePublished":"2026-08-26T04:39:58+00:00","dateModified":"2026-08-26T04:39:59+00:00","description":"Takeda Pharmaceutical Company Limited China (TYO: 4502; NYSE: TAK) entered into a partnership agreement with Ant Group, combining Takeda's expertise and medical insights in key disease areas with Ant Group's strengths in artificial intelligence (AI), digital platforms, and ecosystem connectivity. The two parties will collaborate around patient needs and healthcare service scenarios, exploring new models for digital technology\u2011enabled healthcare innovation and driving healthcare services toward full\u2011lifecycle, data\u2011driven, intelligent, and health\u2011centric development.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=76653#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=76653"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=76653#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/2603.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/2603.webp","width":1080,"height":608,"caption":"Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI\u2011Driven Patient Care in China"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=76653#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Takeda and Ant Group Form Digital Healthcare Partnership to Advance AI\u2011Driven Patient Care in China"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/2603.webp","_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/76653","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=76653"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/76653\/revisions"}],"predecessor-version":[{"id":76656,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/76653\/revisions\/76656"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/76655"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=76653"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=76653"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=76653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}